GT Molecular, a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels has implemented a highly sensitive, wastewater-based test for hMPXV.
| dPCR Testing and Rapid NGS Services for Wastewater FORT COLLINS, Colo., July 28, 2022 /PRNewswire/ -- GT Molecular, a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels has implemented a highly sensitive, wastewater-based test for hMPXV. This test features robust quality control metrics, including an internal process control and fecal indicator.
GT Molecular offers hMPXV (human Monkeypox) Testing/PCR Kits & NGS/dPCR Wastewater Testing for SARS-CoV-2 Variants Current offerings: 1. Testing Service and PCR kits for hMPXV (Human Monkeypox Virus) & SARS-CoV-2 Variants
2. Rapid National dPCR and NGS Service and PCR kits for SARS-CoV-2 Variants in Wastewater
3. GenomeWeb Webinar on July 28, 2022! Register at: https://www.gtmolecular.com/hmpxv-testing-pcr-kits The company is empowering hundreds of academic, commercial, and public testing laboratories around the world with its easy-to-use and accurate PCR assay kits and its national testing and sequencing services. About GT Molecular GT Molecular is a leader in providing highly customizable, ultrasensitive, digital PCR and qPCR tests. GTM’s patent-pending assay technology provides a user friendly, out-of-box solution for rapid deployment and yields reliable and consistent measurements while detecting as little as 3 molecules of target nucleic acid. The company has a growing catalog of molecular assays that includes SARS-CoV-2 multi-variant tests, cancer panels and multiplexed pathogen panels. ORDER & INFORMATION: info@gtmolecular.com
SOURCE GT Molecular |
View original content to download multimedia: